Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc.

A case in which the Court will decide (1) when a generic drug manufacturer excludes a patented use from its label, whether it still be liable for inducing infringement if it calls its product a “generic version” of the brand-name drug and cites publicly available information about the brand-name drug's sales; and (2) whether a patent infringement complaint can survive dismissal if it does not allege that the defendant made any statement specifically instructing or encouraging the patented use.

You can listen to Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. online on Radio and Podcast. Open the player on this page to stream the available audio.

Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. is an episode from U.S. Supreme Court Oral Arguments.

This episode is 60:20 long.

This episode was published on Apr 29, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from U.S. Supreme Court Oral Arguments when more episodes are available from the podcast feed.